GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » YoY EPS Growth

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) YoY EPS Growth : 72.73% (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Zhejiang Huahai Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Sep. 2024 was 72.73%.

Zhejiang Huahai Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ¥0.19.


Zhejiang Huahai Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co YoY EPS Growth Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 400.00 56.10 -46.88 135.29 -28.75

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.25 -72.00 58.33 22.22 72.73

Zhejiang Huahai Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Zhejiang Huahai Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(0.57-0.8)/ | 0.8 |
=-28.75 %

Zhejiang Huahai Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(0.19-0.11)/ | 0.11 |
=72.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Huahai Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Zhejiang Huahai Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huahai Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xunqiao, Zhejiang Province, Linhai, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in Research & Development, production and sales of multi-dosage preparations, biological drugs, innovative drugs and specialty APIs.
Executives
Lin Li Hong senior management
Xu Mi senior management
Gang Hui senior management
He Bin senior management
Kong Xiao Fang senior management
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Chen Qi Mao senior management

Zhejiang Huahai Pharmaceutical Co Headlines

No Headlines